| | Patient characteristics | Values |
| | Age (median (range)) | 64.5 (10–87) |
| | Sex, male/female, n | 18/12 |
| | Indication for surgery | | PDAC | 9 | | NET | 6 | | SPN | 5 | | IPMN | 4 | | LDLT | 2 | | LC | 1 | | LEC | 1 | | Liposarcoma | 1 | | MPD stricture | 1 |
| | Type of initial surgery | | DP with splenectomy | 18 | | SPDP | 5 | | Enucleation | 2 | | LDLT | 2 | | DP-CAR | 1 | | Splenectomy | 1 | | Retroperitoneal tumor resection | 1 | | With/without splenectomy | 22/8 | | Open/laparoscopic | 13/17 |
| | Indication for POPF drainage | | Infection | 19 | | Pain | 7 | | Asymptomatic | 2 | | Others | 2 | | Size of POPF (mm, median (range)) | 69.5 (38–145) |
| | Location of POPF | | Ph | 4 | | Pbt | 26 |
| | Drainage approach | | Transgastric | 29 | | Transduodenal | 1 |
| | Type of drainage | | Simultaneous internal and external drainage | 12 | | Internal drainage only | 15 | | Aspiration | 3 | | Plastic stent/LAMS | 23/4 |
| | Number of treatment sessions | | 1 | 21 | | 2 | 6 | | 3 | 2 | | 4 | 1 |
| | Period between surgery and EUS-TD (days, median (range)) | 17.5 (3–232) | | Hospital stay period after EUS-TD (days, median (range)) | 16.5 (5–88) | | Technical success (n, %) | 30 (100) | | Clinical success (n, %) | 29 (97) | | Complications (n, %) | 2 (6.9) | | Observation period (months, median (range)) | 14 (0.6–117) |
|
|
POPF, postoperative pancreatic fistula; PDAC, pancreatic ductal adenocarcinoma; NET, neuroendocrine tumor; SPN, solid pseudopapillary neoplasm; IPMN, intraductal papillary mucinous neoplasm; LDLT, living donor liver transplantation; LC, liver cirrhosis; LEC, lymphoepithelial cyst; MPD, main pancreatic duct; DP, distal pancreatectomy; SPDP, spleen-preserving distal pancreatectomy; DP-CAR, distal pancreatectomy with celiac axis resection; LAMS, lumen-apposing metal stent; EUS-TD, EUS-guided transluminal drainage.
|
